Clinical Trials Browser

INDUSTRY × Has results × guadecitabine × Clear all

NCT01696032 2024-08-27

SGI-110

Phase 2 Completed

120 enrolled 22 charts

Ovarian Neoplasms

NCT01752933 2024-08-27

SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC)

Phase 2 Completed

52 enrolled 14 charts

Gastrointestinal

Carcinoma, Hepatocellular

NCT02907359 2024-08-27

Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs

Phase 3 Completed

417 enrolled 24 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT03603964 2024-08-27

Guadecitabine Extension Study

Phase 2 Terminated

35 enrolled 10 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT02293993 2021-03-05

Phase 1 Study of SGI-110 in Patients With Acute Myeloid Leukemia

Phase 1 Completed

21 enrolled 13 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute